However, in patients with stable CAD, NT-proBNP did not improve the prognostic power of a clinical model based on traditional clinical risk factors, echocardiographic parameters, ischemia, other biomarkers, and New York Heart Association class [19]. Here, NPPB is linked to coronary artery disorder.